1 completed, 1 recruiting, 1 terminated. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Recruiting 1, Terminated 1 |
Follow Cutaneous Tumor: new trials by email Literature Review of Cutaneous Tumor trials Research Report on Cutaneous Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors tolododekin alfa, Cemiplimab - Advanced Solid Tumor, Cutaneous Tumor | Phase 1 | Recruiting | Ankyra Therapeutics, Inc | 97 | 2024-01-19 | 2026-03-06 |
| Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors JCXH-211 Injection - Cutaneous Tumor, Malignant Solid Tumor | Phase 1 | Completed | Immorna Biotherapeutics, Inc. | 19 | 2023-02-24 | 2026-11-09 |
| Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors JCXH-211 - Cutaneous Tumor, Malignant Solid Tumor | Phase 1 | Terminated | Immorna Biotherapeutics, Inc. | 1 | 2022-10-19 | 2026-11-05 |
Skin Neoplasms (3) · Neoplasms (2) · Carcinoma, Non-Small-Cell Lung (1) · Neoplasm Metastasis (1)
Neoplasms by Site (3) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Lung Diseases (1) · Lung Neoplasms (1) · Neoplasms (1) · Neoplastic Processes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Respiratory Tract Diseases (1) · Respiratory Tract Neoplasms (1) · Thoracic Neoplasms (1)
cemiplimab (1)
Immorna Biotherapeutics, Inc. (2) · Ankyra Therapeutics, Inc (1)
United States (3) · Canada (1) · China (1)